重症监护病房内侵袭性A组链球菌感染:一项多中心回顾性队列的无监督聚类分析
这项多中心回顾性研究纳入2018年3月1日至2023年8月1日巴黎大学医院9个ICU收治的148例侵袭性A组链球菌(iGAS)感染患者,使用k-prototypes聚类算法基于入ICU时的临床和生物学变量进行分组。根据Silhouette标准分为3个聚类,7例未分类。聚类1(n=73)多为病情较轻的女性,有疼痛性皮肤软组织感染,其中四分之一曾使用非甾体抗炎药;聚类2(n=42)以呼吸道感染为主,常合并病毒感染;聚类3(n=26)多为社会剥夺患者,慢性酒精滥用和精神疾病比例高,皮肤软组织感染症状轻微但器官功能障碍严重。各聚类间感染源控制时间无显著差异,聚类2接受抗毒素抗生素的比例较低,需要ECMO支持的趋势较高,聚类1接受有创机械通气的比例较低,但ICU死亡率无显著差异。作者认为,基于简单易得的入ICU特征可识别3种在ICU管理上存在差异的患者群体,但量身定制的管理是否影响结局需进一步研究。
要点
- 在148例iGAS重症患者中,无监督聚类识别出3种表型:聚类1(n=73)病情较轻女性伴疼痛性皮肤软组织感染,聚类2(n=42)以呼吸道感染为主常合并病毒感染,聚类3(n=26)社会剥夺患者伴严重器官功能障碍但皮肤软组织感染症状轻微。
- 聚类2接受抗毒素抗生素的比例显著低于聚类1和聚类3(45% vs 79% vs 69%,p<0.001)。
- 聚类1接受有创机械通气的比例显著低于聚类2和聚类3(48% vs 74% vs 77%,p=0.005)。
- 聚类2需要ECMO支持的比例有高于其他聚类的趋势(12% vs 3% vs 0%,p=0.07)。
- 各聚类间ICU死亡率无显著差异(19% vs 29% vs 31%,p=0.32),感染源控制时间也无显著差异(0[0-0] vs 0[0-0] vs 0[0-1]天,p=0.12)。
适用人群与场景
- 2018年3月1日至2023年8月1日期间入住巴黎大学医院9个ICU中任何一个的iGAS感染患者。
- iGAS感染定义为任何来自无菌部位的微生物样本中培养出A组链球菌。
诊断标准与关键阈值
- iGAS感染定义:任何来自无菌部位的微生物样本中培养出A组链球菌。
研究设计与关键结果
- 研究类型:多中心回顾性队列研究,纳入9个ICU的148例患者,使用k-prototypes聚类算法基于入ICU时临床和生物学变量分组。
- 根据Silhouette标准分为3个聚类,7例未分类;聚类1(n=73)多为病情较轻女性,有疼痛性皮肤软组织感染,四分之一曾使用非甾体抗炎药;聚类2(n=42)以呼吸道感染为主,常合并病毒感染;聚类3(n=26)多为社会剥夺患者,慢性酒精滥用和精神疾病比例高,皮肤软组织感染症状轻微但器官功能障碍严重。
- 感染源控制时间在各聚类间无显著差异(0[0-0] vs 0[0-0] vs 0[0-1]天,p=0.12)。
- 聚类2接受抗毒素抗生素的比例显著低于聚类1和聚类3(45% vs 79% vs 69%,p<0.001)。
- 聚类2需要ECMO支持的比例有高于聚类1和聚类3的趋势(12% vs 3% vs 0%,p=0.07)。
- 聚类1接受有创机械通气的比例显著低于聚类2和聚类3(48% vs 74% vs 77%,p=0.005)。
- 各聚类间ICU死亡率无显著差异(19% vs 29% vs 31%,p=0.32)。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于简单易得的入ICU临床特征可识别3种在ICU管理上存在差异的iGAS患者群体,但量身定制的管理是否影响结局需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Invasive group A streptococcus (iGAS) infection incidence is rising. These infections have been studied as a whole but can be associated with critical illness in a population with a wide array of underlying conditions, sites of infection and clinical presentations. Using an unsupervised clustering approach, we aimed to identify specific clinical phenotypes regarding presentation, management and outcome.
METHODS: This was a retrospective multicentric study including all patients admitted to one of 9 ICUs of Paris University Hospitals for an iGAS infection between 01/03/2018 and 01/08/2023. iGAS infection was defined as GAS growth in any microbiological sample from a sterile site. Patients were grouped according to a clustering algorithm (k-prototypes) using a comprehensive set of clinical and biological variables available upon ICU admission. Clusters were described and clinical presentation, management and outcome were compared.
RESULTS: 148 patients were included. According to the Silhouette criterion, patients were grouped in 3 clusters, and 7 patients remained unclassified. Cluster 1 (n = 73) comprised a greater proportion of less severely-ill female patients with painful skin and soft tissue infections, a quarter of whom had taken non-steroidal anti-inflammatory drugs. Cluster 2 (n = 42) was characterized by a high rate of respiratory infections with frequent viral co-infections. Cluster 3 (n = 26) included mostly socially deprived patients with high rates of chronic alcohol consumption and psychiatric illness, with severe organ dysfunction related to otherwise pauci-symptomatic skin and soft tissue infections. There was no significant difference in time to source control across clusters (0 [0-0] vs 0 [0-0] vs 0 [0-1] days, p = 0.12). Patients included in cluster 2 less frequently received antitoxin antibiotics than patients from clusters 1 and 3 (79% vs 45% vs 69%, p < 0.001) and tended to more frequently require ECMO support (3% vs 12% vs 0%, p = 0.07), while those from cluster 1 were less likely to receive invasive mechanical ventilation (48% vs 74% vs 77%, p = 0.005). There was no difference in ICU-mortality between clusters (19% vs 29% vs 31%, p = 0.32).
CONCLUSIONS: Based on simple and readily available clinical admission characteristics of critically ill patients with iGAS, unsupervised clustering analysis identified three specific patient populations that differed regarding ICU management. Whether tailoring management would affect outcome warrants further research.
参考来源
- Urbina T, Faucheux L, Lavillegrand JR, et al. Invasive group A streptococcus infections in the intensive care unit: an unsupervised cluster analysis of a multicentric retrospective cohort. Crit Care. 2025. PMID: 40506732. doi:10.1186/s13054-025-05469-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。